Lung Cancer Working Group

multistakeholder platform with a mission to help improve efficiency in lung cancer care

Although lung cancer represents 13% of the total number of cancer cases in Belgium, there is a lack of support for lung cancer patients compared to other types of cancer like breast cancer. There is a need for more efficiency along the pathway to improve outcomes, such as lung cancer screening, prevention, and patient support.

With new cancer treatments being developed, digitization of healthcare that is advancing and shifting demographics in survivorship of lung cancer, a multistakeholder group focusing on lung cancer can facilitate the development and adoption of solutions for efficient cancer care for lung cancer patients in Belgium.

We believe that collaborating, across boundaries of each organization and as equal partners, is the best way to create a positive impact on the care and quality of life for patients and their families living with lung cancer in Belgium.

The ambition of this Lung Cancer Working Group is to bring stakeholders together to works towards optimal lung cancer care by setting thematic priorities that are supported by each of the stakeholders.

By leveraging the collaboration between patient organizations, patient representatives, healthcare professionals, policy and industry, our Lung Cancer Working Group aims to address those areas where patient needs are the highest.
Prof. dr. Paul Van Schil

Prof. dr. Paul Van Schil

President of IASLC 2023-2025

Prof. dr. Paul Van Schil

Prof. dr. Ingel Demedts

Prof. dr. Ingel Demedts

Chairman of the LCWG - Pulmonologist-thoracic oncologist AZ Delta

Prof. dr. Ingel Demedts

Dr. Didier Vander Steichel

Dr. Didier Vander Steichel

Dr. Didier Vander Steichel

Didier Vander Steichel is the Medical and Scientific Director at the Belgian cancer fund – Stichting tegen Kanker / Fondation contre le Cancer. With extensive expertise in patient information, patient support, prevention and funding of academic cancer research, along with fruitful partnerships, this independent NGO has a comprehensive understanding of what works and what is missing. Regular input from researchers, clinicians, caregivers, patients and their relatives across the entire care spectrum, from prevention to palliative care, further enhance its perspective.

“Efficiency, multidisciplinarity, patient-centricity and patient empowerment are key to sustainable progress in cancer research, care and cure.”

Florence Duvieusart

Florence Duvieusart

Florence Duvieusart

Bart Croes

Bart Croes

Bart Croes

Danielle Derijcke

Danielle Derijcke

Danielle Derijcke

Prof. dr. Jan Van Meerbeeck

Prof. dr. Jan Van Meerbeeck

Longarts-oncoloog/Thoracic Oncologist UZA

Prof. dr. Jan Van Meerbeeck

“Being member of AllCan Belgium allows me to liaise indepently with non-medical stakeholders in the care process of cancer with the aim to improve its overall efficiency and sustainability.”

Cassandra Lecomte

Cassandra Lecomte

Cassandra Lecomte

Johan Thibo

Johan Thibo

Inspiring survivor

Johan Thibo

Ina Gesquiere

Ina Gesquiere

Ina Gesquiere

Prof. dr. Thierry Berghmans

Prof. dr. Thierry Berghmans

Thoracic oncologist Insititut Jules Bordet

Prof. dr. Thierry Berghmans

Dr. Kristof Cuppens

Dr. Kristof Cuppens

Pulmonologist Thoracic oncologist Jessa Ziekenhuis

Dr. Kristof Cuppens

Ann Curias

Ann Curias

Ann Curias

André Stoop

André Stoop

André Stoop

Mitchell Silva

Mitchell Silva

Mitchell Silva